collegium
appoints
rita
board
directors
stoughton
globe
newswire
collegium
pharmaceutical
nasdaq
coll
specialty
pharmaceutical
company
committed
leader
responsible
pain
management
today
announced
appointment
rita
board
directors
effective
september
collegium
honored
welcome
rita
board
directors
said
mike
heffernan
founder
chairman
board
collegium
rita
impressive
scientific
expertise
industry
experience
incredibly
valuable
company
confident
make
meaningful
contributions
board
directors
collegium
benefit
insights
continue
commitment
leadership
responsible
pain
excited
opportunity
join
collegium
board
important
time
company
evolution
look
forward
working
board
management
team
make
positive
difference
lives
people
suffering
pain
said
rita
rita
served
chief
scientific
officer
muna
therapeutics
newly
formed
biotech
company
focused
developing
novel
therapeutics
patients
neurodegenerative
diseases
since
may
novo
seeds
since
august
previously
served
scientific
roles
increasing
responsibility
sanofi
recently
global
head
rare
neurological
diseases
prior
joining
sanofi
led
psychiatry
pain
drug
discovery
portfolios
vice
president
neuroscience
pain
research
unit
pfizer
inc
earlier
career
professor
neuroscience
chair
neuroscience
graduate
group
university
pennsylvania
perelman
school
medicine
currently
holds
appointment
adjunct
professor
department
neuroscience
authored
scientific
papers
received
numerous
accolades
work
field
neuroscience
chaired
served
many
nih
national
international
committees
received
degree
biological
sciences
northwestern
university
neurobiology
university
texas
austin
collegium
pharmaceutical
collegium
specialty
pharmaceutical
company
committed
leader
responsible
pain
management
collegium
headquarters
located
stoughton
massachusetts
information
please
visit
company
website
statements
press
release
contains
statements
within
meaning
private
securities
litigation
reform
act
may
cases
use
terms
predicts
forecasts
believes
potential
proposed
continue
estimates
anticipates
expects
plans
intends
may
could
might
words
convey
uncertainty
future
events
outcomes
identify
statements
management
expectations
therefore
statements
press
release
could
also
affected
risks
uncertainties
relating
number
factors
including
impact
pandemic
ability
conduct
business
reach
customers
supply
market
products
risks
described
heading
risk
factors
quarterly
report
form
quarter
ended
june
filings
sec
statements
make
press
release
speak
date
press
release
assume
obligation
update
statements
whether
result
new
information
future
events
otherwise
date
press
release
contact
alex
dasalla
adasalla
